Table 2.
Description of harm reduction services regularly provided by centres and number of users per centre (n = 11) during the first 6 months of the years 2019 and 2020, Spain (n = 11)
| Centre (city name) |
n. users 2019 (Jan–June) |
n. users 2020 (Jan–June) |
NSP | SIR | Naloxone distribution | Education services | Mental health services | OST | HCV DAA | HIV ART | HBV testing | HCV testing | HIV testing | TB testing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Centre 1 (Badalona) | 265 | 274 | ✓ | ✓ | ✓ | ✓ | ||||||||
| Centre 2 (Bilbao) | 923 | 721 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||||||
|
Centre 3 (Madrid) |
4528 | 1945 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |
|
Centre 4 (Madrid) |
892 | 1090 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |
|
Centre 5 (Vitoria-Gasteiz) |
77 | 60 | ✓ | ✓ | ✓ | ✓ | ||||||||
|
Centre 6 (Bilbao) |
1267 | 1080 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||||
|
Centre 7 (Reus) |
394 | 398 | ✓ | ✓ | ✓ | ✓ | ✓ | |||||||
|
Centre 8 (Valencia) |
764 | 687 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||
|
Centre 9 (Bilbao) |
1365 | 679 | ✓ | ✓ | ✓ | |||||||||
|
Centre 10 (El Prat de Llobregat) |
2652 | 3351 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||||
|
Centre 11 (Barcelona) |
N/A | N/A | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||
|
Centre 12 (Barcelona) |
N/A | N/A | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |
|
Centre 13 (Sant Adrià de Besos) |
6166 | 3912 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||||
| Total | 13 | 4 | 8 | 12 | 13 | 7 | 7 | 5 | 6 | 9 | 9 | 6 |
NSP Needle and syringe programme, SIR supervised injecting room, OST opioid substation therapy, DAA direct acting antivirals, HBV hepatitis B virus, HCV hepatitis C virus, HIV human immunodeficiency virus (HIV), TB tuberculosis, N/A not available